all prices

price high low   %
Dow Jones 26313 26391 26083 -0.1 %
S&P500 3117 3129 3090 -0.28 %
Nasdaq 100 9637 9743 9576 -0.64 %
Euro Stoxx 50 3254 3292 3230 -0.62 %
FTSE 100 6332 6398 6307 -0.78 %
CAC40 4998 5052 4963 -0.69 %
DAX 12415 12563 12330 -0.88 %
Hong Kong HSI 24262 24682 24221 -1.95 %
Nikkei 225 22761 22944 22502 -0.75 %

Live stock markets prices

Dow Jones 26306 -0.13%
S&P500 3116 -0.3%
Nasdaq 100 9635 -0.66%
FTSE 100 6332 -0.78%
CAC40 4998 -0.69%
Nikkei 225 22751 -0.79%
Euro Stoxx 50 3254 -0.62%
DAX 12415 -0.88%

Latest news

Uranium Participation Corporation Reports Estimated Net Asset Value, Uranium Sales, Uranium Loans and Share Purchases at May 31, 2020
Clinicians and scientists apply symptom tracking to COVID-19 outpatient care using famotidine
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Reminds Conn's, Inc. Investors of Important July 14 Deadline in Securities Class Action - CONN
Pond Technologies Announces $1,000,000 Private Placement Offering of Units
BGL Announces Merger of Synergy Surgicalists and EA Health Solutions, With a Simultaneous Recapitalization by Enhanced Healthcare Partners
NorZinc Announces Results of Annual General Meeting of Shareholders
Century Communities Ranks #9 On 2020 Builder 100 List
Coronavirus (COVID-19) Update: Daily Roundup
Fraser States Organizational Commitment to Anti-Racism and Support for Community
TeamChildren and the Andrew Hicks Foundation Donate 25 Laptops to College Bound Chester High Students
American Exchange Group partners with Sanrio® for new collection of Hello Kitty® smartwatches for kids
Dr. Kiran Mazumdar-Shaw from India named EY World Entrepreneur Of The Year(TM) 2020
DLA Piper advises Iovance Biotherapeutics in its US$604 million common stock offering
Pond Technologies Holdings Inc. Announces Filing of 2019 Year-End Audited Financial Statements and MD&A
The Province of Buenos Aires Extends Expiration of Invitation Memorandum (as defined below)
Mountain Crest Acquisition Corp Announces Pricing of $50 Million Initial Public Offering
Proof of Harm To CA's Unborn From Proximity To Oil Wells Proves Need For Barrier Between Wells And People, Says Consumer Watchdog
Philadelphia Administrators' Union Protests Racial Injustice, Honors George Floyd With Silent March
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Reminds iAnthus Capital Holdings, Inc. Investors to Contact Firm Before June 15 Deadline in Class Action Seeking Recovery of Investor Losses - ITHUF
XLCS Partners advises Nortech Packaging and Tishma Technologies in sale to Intertape Polymer Group
Thursday, 4 June 2020, 18:43

Uranium Participation Corporation Reports Estimated Net Asset Value, Uranium Sales, Uranium Loans and Share Purchases at May 31, 2020

TSX Trading symbol: U

TORONTO, June 4, 2020 /CNW/ - Uranium Participation Corporation ("UPC") (TSX:U) reports its estimated net asset value at May 31, 2020 was CAD$819.9 million or CAD$6.00 per share. As at May 31, 2020, UPC's uranium investment portfolio consisted of the following: View PDF version.

(in thousands of Canadian dollars, except quantity amounts)



Fair Value

Investments in Uranium:

Uranium oxide in concentrates ("U3O8")

  15,562,101   lbs



Uranium hexafluoride ("UF6")

600,000 KgU





U3O8 fair value1 per pound:

- In Canadian dollars1



- In United States dollars



UF6 fair value1 per KgU:

- In Canadian dollars1



- In United States dollars



1 Fair values are month-end spot prices published by Ux Consulting Company, LLC, translated at the Bank of
Canada's month-end daily exchange rate of $1.3787.

On the last trading day of May 2020, the common shares of UPC closed on the TSX at a value of CAD$5.12, which represents a 14.67% discount to the net asset value of CAD$6.00 per share.

On April 14, 2020, UPC announced that it had received approval from the TSX to acquire for cancellation, by way of a normal course issuer bid ('NCIB'), up to 12,301,750 common shares of the Corporation, during the period from April 16, 2020 to April 15, 2021.

During May 2020, the Corporation repurchased, for cancellation, 901,864 common shares at a weighted average price of CAD$4.94 for a total purchase price of CAD$4,455,000. Of these shares, 569,514 shares were purchased and held by UPC's broker at the end of May 2020, but had not yet been transferred to UPC for cancellation.  Accordingly, the Corporation's estimated net asset value at May 31, 2020 includes a liability of $2,808,000 related to the trades yet to be settled and its issued and outstanding shares has not be reduced for the shares yet to be cancelled. As the trades settle in early June 2020, the shares are cancelled. 

The share repurchase reported for the month of May 2020 were financed through a combination of existing working capital and the sale of 100,000 pounds of U3O8 at a weighted average purchase price of USD$33.48 per pound, for estimated gross proceeds of CAD$4,713,000. The 100,000 pounds U3O8 sold in May includes a 50,000 pound U3O8 sale transaction entered into on April 30, 2020 and reported in the Company's April 2020 press release.

The net asset value per share of CAD$6.00 has been calculated using a pro forma issued and outstanding share amount of 136,688,311, which reflects the Corporation's issued and outstanding shares at May 31, 2020, less the 569,514 shares which were held for cancellation.

In addition, during the month of May, the Corporation entered into a fully collateralized short-term uranium lending agreement whereby UPC loaned 500,000 pounds of U3O8 to a counterparty for a monthly loan fee of USD$100,000. The total fees to be earned over the term of the arrangement is anticipated to be USD$400,000.

As previously reported (in UPC's news release dated November 14, 2019), UPC has entered into commitments to sell the conversion component contained in 300,000 KgU as UF6 ("Conversion Sale") and to purchase a total of 230,000 pounds of U3O8 ("Uranium Purchase").  The Conversion Sale will result in the exchange of 300,000 KgU as UF6 for 783,856 pounds of U3O8 and cash consideration of USD$6,087,000, and will occur in three equal tranches of 100,000 KgU as UF6 for delivery in January 2020, June 2020, and July 2020.  The Uranium Purchase involves the acquisition of three tranches of 100,000 pounds U3O8, 76,300 pounds U3O8, and 53,700 pounds U3O8, for delivery in October 2019, January 2020, and June 2020, respectively, at an average price of USD$26.04. In October 2019, UPC took delivery of the first tranche of 100,000 pounds U3O8.  In January 2020, the first Conversion Sale was completed which resulted in an exchange of 100,000 KgU as UF6 for 261,285 pounds of U3O8, and UPC also took delivery of the Uranium Purchase's second tranche of 76,300 pounds U3O8.

Following the completion of the various uranium transactions described above, UPC expects to hold a total of 16,138,372 pounds U3O8, and 400,000 KgU as UF6. The completion of these transaction is also expected to result in a net cash inflow of USD$2,927,000 during the second quarter of fiscal 2021.

About Uranium Participation Corporation

Uranium Participation Corporation is a company that invests substantially all of its assets in uranium oxide in concentrates ("U3O8") and uranium hexafluoride ("UF6") (collectively "uranium"), with the primary investment objective of achieving appreciation in the value of its uranium holdings through increases in the uranium price. UPC provides investors with a unique opportunity to gain exposure to the price of uranium without the resource or project risk associated with investing in a traditional mining company. Additional information about Uranium Participation Corporation is available on SEDAR at and on UPC's website at

Caution Regarding Forward-Looking Information

This press release contains certain forward-looking statements and forward-looking information that are based on UPC's current internal expectations, estimates, projections, assumptions and beliefs. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may", "will", "expect", "intent", "estimate", "anticipate", "plan", "should", "believe" or "continue" or the negative thereof or variations thereon or similar terminology and include statements with respect to the NCIB and UPC's plans with respect thereto; UPC's investment objectives, its uranium holdings, the transactions entered into with third parties, and agreements with respect thereto.

By their very nature, forward-looking statements involve numerous factors, assumptions and estimates. A variety of factors, many of which are beyond the control of UPC, may cause actual results to differ materially from the expectations expressed in the forward-looking statement. These factors include, but are not limited to, changes in commodity prices and foreign exchange as well as the risk that UPC will not obtain the anticipated benefits of its agreements with third parties. For a description of the principal risks of UPC, see "Risk Factors" in UPC's Annual Information Formed dated May 27, 2020 for the fiscal year ended February 29, 2020, a copy of which is available at

These and other factors should be considered carefully, and readers are cautioned not to place undue reliance on these forward-looking statements. Although management reviews the reasonableness of its assumptions and estimates, unusual and unanticipated events may occur which render them inaccurate. Under such circumstances, future performance may differ materially from those expressed or implied by the forward-looking statements. Except where required under applicable securities legislation, UPC does not undertake to update any forward-looking information statement.

Uranium Participation Corporation Reports Estimated Net Asset Value, Uranium Sales, Uranium Loans and Share Purchases at May 31, 2020 (CNW Group/Uranium Participation Corporation)

SOURCE Uranium Participation Corporation

  Log in